Mandate

Vinge advises when Lendify, a fintech company and one of Sweden’s largest challengers to the banking sector, completes a share issue of SEK 148m

April 22, 2020 M&A

Vinge has advised Lendify AB (publ) (”Lendify”) in connection with raising of capital from new and current shareholders in an investment round in a total amount of approximately SEK 148 million.

The issue occurs at a valuation of Lendify of approximately SEK 1.5 billion (prior to the investment).

Vinge’s team primarily consisted of partner Jonas Johansson together with associates Filip Öhrner, Anna Thoms and Hanna Risberg.

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025